This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
DocuSign (DOCU) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
DocuSign (DOCU) delivered earnings and revenue surprises of 21.25% and 1.36%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
Yext (YEXT) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Yext (YEXT) delivered earnings and revenue surprises of 150% and 0.22%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
DocuSign Stock Before Q2 Earnings: To Buy or Not to Buy?
by Shuvra Shankar Dey
DOCU's second-quarter fiscal 2025 earnings and revenues are likely to increase year over year.
DocuSign (DOCU) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for DocuSign (DOCU), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2024.
DocuSign (DOCU) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
DocuSign (DOCU) closed the most recent trading day at $58.46, moving -0.44% from the previous trading session.
Allot Communications (ALLT) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Allot Communications (ALLT) delivered earnings and revenue surprises of 50% and 0.61%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Why DocuSign (DOCU) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AppLovin Corporation (APP) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
AppLovin (APP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Investors Heavily Search Docusign Inc. (DOCU): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to DocuSign (DOCU). This makes it worthwhile to examine what the stock has in store.
Reasons to Retain Insperity (NSP) Stock in Your Portfolio Now
by Zacks Equity Research
Insperity (NSP) relies on its diversified revenue base to mitigate market risks.
DocuSign (DOCU) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
The latest trading day saw DocuSign (DOCU) settling at $56.87, representing a -0.56% change from its previous close.
Here's Why You Should Retain Accenture (ACN) Stock for Now
by Zacks Equity Research
Accenture's (ACN) disciplined acquisition strategy focuses on channeling its business in high-growth areas, adding skills and capabilities, and deepening industry and functional expertise.
Here's Why You Should Retain IQVIA (IQV) Stock for Now
by Zacks Equity Research
IQVIA (IQV) rides high on robust segmental performance, boosting the company's top line. However, elevated operating expenses and weak liquidity are a major concern.
Bakkt Holdings, Inc. (BKKT) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Bakkt (BKKT) delivered earnings and revenue surprises of -50.85% and 41.87%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Amprius Technologies (AMPX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Amprius (AMPX) delivered earnings and revenue surprises of -18.18% and 36.48%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why DocuSign (DOCU) Outpaced the Stock Market Today
by Zacks Equity Research
DocuSign (DOCU) concluded the recent trading session at $50.58, signifying a +1.71% move from its prior day's close.
Here is What to Know Beyond Why Docusign Inc. (DOCU) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching DocuSign (DOCU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why DocuSign (DOCU) Outpaced the Stock Market Today
by Zacks Equity Research
In the most recent trading session, DocuSign (DOCU) closed at $55.90, indicating a +1.45% shift from the previous trading day.
DocuSign (DOCU) Laps the Stock Market: Here's Why
by Zacks Equity Research
The latest trading day saw DocuSign (DOCU) settling at $56.62, representing a +1.31% change from its previous close.
DocuSign (DOCU) Dips 12% in 6 Months: Is the Stock Worth Buying?
by Shuvra Shankar Dey
Given the recent decline in DocuSign (DOCU) shares, we evaluate the stock's current position to determine whether it presents a good investment opportunity at this time.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Docusign Inc. (DOCU) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching DocuSign (DOCU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DocuSign (DOCU) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
In the closing of the recent trading day, DocuSign (DOCU) stood at $57.14, denoting a +1.34% change from the preceding trading day.